logologologo

Intellectual Property focused on
Patents, Technology & Business

  • About the Firm
  • Team
    • Pedro Berkenwald
    • Alicia Alvarez Berkenwald
    • Anahí Cordero
    • Ernesto Machicote
    • Federico Ulled
    • Lucía Scarpati
    • Bárbara Porcario
    • Emilio Berkenwald
    • Elena R. Pérez
    • María Aurora García
    • Melisa San Juan
    • Federico Maddonni Brito
    • Guadalupe Ocampo
    • Daiana Melman
    • Guadalupe Cartagena
  • Technology Areas
    • Biotechnology, Chemical & Pharmaceutical
    • Electronics and Information Technology
    • Industrial Chemistry and Mechanics
  • Services
    • Intellectual Property Prosecution
    • Legal Affairs
    • Patent Intelligence
  • Clients
    • Companies
    • Scientific Community
    • Associates
  • Blog
  • Contact Us
  • Spanish
  • English
logologologo

Intellectual Property focused on
Patents, Technology & Business

  • About the Firm
  • Team
    • Pedro Berkenwald
    • Alicia Alvarez Berkenwald
    • Anahí Cordero
    • Ernesto Machicote
    • Federico Ulled
    • Lucía Scarpati
    • Bárbara Porcario
    • Emilio Berkenwald
    • Elena R. Pérez
    • María Aurora García
    • Melisa San Juan
    • Federico Maddonni Brito
    • Guadalupe Ocampo
    • Daiana Melman
    • Guadalupe Cartagena
  • Technology Areas
    • Biotechnology, Chemical & Pharmaceutical
    • Electronics and Information Technology
    • Industrial Chemistry and Mechanics
  • Services
    • Intellectual Property Prosecution
    • Legal Affairs
    • Patent Intelligence
  • Clients
    • Companies
    • Scientific Community
    • Associates
  • Blog
  • Contact Us
  • Spanish
  • English
logologologo

Intellectual Property focused on
Patents, Technology & Business

  • About the Firm
  • Team
    • Pedro Berkenwald
    • Alicia Alvarez Berkenwald
    • Anahí Cordero
    • Ernesto Machicote
    • Federico Ulled
    • Lucía Scarpati
    • Bárbara Porcario
    • Emilio Berkenwald
    • Elena R. Pérez
    • María Aurora García
    • Melisa San Juan
    • Federico Maddonni Brito
    • Guadalupe Ocampo
    • Daiana Melman
    • Guadalupe Cartagena
  • Technology Areas
    • Biotechnology, Chemical & Pharmaceutical
    • Electronics and Information Technology
    • Industrial Chemistry and Mechanics
  • Services
    • Intellectual Property Prosecution
    • Legal Affairs
    • Patent Intelligence
  • Clients
    • Companies
    • Scientific Community
    • Associates
  • Blog
  • Contact Us
  • Spanish
  • English
logologologo

Intellectual Property focused on
Patents, Technology & Business

  • About the Firm
  • Team
    • Pedro Berkenwald
    • Alicia Alvarez Berkenwald
    • Anahí Cordero
    • Ernesto Machicote
    • Federico Ulled
    • Lucía Scarpati
    • Bárbara Porcario
    • Emilio Berkenwald
    • Elena R. Pérez
    • María Aurora García
    • Melisa San Juan
    • Federico Maddonni Brito
    • Guadalupe Ocampo
    • Daiana Melman
    • Guadalupe Cartagena
  • Technology Areas
    • Biotechnology, Chemical & Pharmaceutical
    • Electronics and Information Technology
    • Industrial Chemistry and Mechanics
  • Services
    • Intellectual Property Prosecution
    • Legal Affairs
    • Patent Intelligence
  • Clients
    • Companies
    • Scientific Community
    • Associates
  • Blog
  • Contact Us
  • Spanish
  • English
logologologo

Intellectual Property focused on
Patents, Technology & Business

  • About the Firm
  • Team
    • Pedro Berkenwald
    • Alicia Alvarez Berkenwald
    • Anahí Cordero
    • Ernesto Machicote
    • Federico Ulled
    • Lucía Scarpati
    • Bárbara Porcario
    • Emilio Berkenwald
    • Elena R. Pérez
    • María Aurora García
    • Melisa San Juan
    • Federico Maddonni Brito
    • Guadalupe Ocampo
    • Daiana Melman
    • Guadalupe Cartagena
  • Technology Areas
    • Biotechnology, Chemical & Pharmaceutical
    • Electronics and Information Technology
    • Industrial Chemistry and Mechanics
  • Services
    • Intellectual Property Prosecution
    • Legal Affairs
    • Patent Intelligence
  • Clients
    • Companies
    • Scientific Community
    • Associates
  • Blog
  • Contact Us
  • Spanish
  • English
logologologo

Intellectual Property focused on
Patents, Technology & Business

  • About the Firm
  • Team
    • Pedro Berkenwald
    • Alicia Alvarez Berkenwald
    • Anahí Cordero
    • Ernesto Machicote
    • Federico Ulled
    • Lucía Scarpati
    • Bárbara Porcario
    • Emilio Berkenwald
    • Elena R. Pérez
    • María Aurora García
    • Melisa San Juan
    • Federico Maddonni Brito
    • Guadalupe Ocampo
    • Daiana Melman
    • Guadalupe Cartagena
  • Technology Areas
    • Biotechnology, Chemical & Pharmaceutical
    • Electronics and Information Technology
    • Industrial Chemistry and Mechanics
  • Services
    • Intellectual Property Prosecution
    • Legal Affairs
    • Patent Intelligence
  • Clients
    • Companies
    • Scientific Community
    • Associates
  • Blog
  • Contact Us
  • Spanish
  • English
  • About the Firm
  • Team
    • Pedro Berkenwald
    • Alicia Alvarez Berkenwald
    • Anahí Cordero
    • Ernesto Machicote
    • Federico Ulled
    • Lucía Scarpati
    • Bárbara Porcario
    • Emilio Berkenwald
    • Elena R. Pérez
    • María Aurora García
    • Melisa San Juan
    • Federico Maddonni Brito
    • Guadalupe Ocampo
    • Daiana Melman
    • Guadalupe Cartagena
  • Technology Areas
    • Biotechnology, Chemical & Pharmaceutical
    • Electronics and Information Technology
    • Industrial Chemistry and Mechanics
  • Services
    • Intellectual Property Prosecution
    • Legal Affairs
    • Patent Intelligence
  • Clients
    • Companies
    • Scientific Community
    • Associates
  • Blog
  • Contact Us
  • Spanish
  • English
by Emilio Berkenwald
IP NewsJuly 7, 20200 comments 0 Likes

Personalized medicine and patents

Personalized medicine is based on the administration of active ingredients to individuals sharing a specific biological feature. It relates to targeted therapies that search for the most appropriate treatment for a given patient, and that are usually presented as the promising future of medicine.

In many cases, the active ingredients used in these treatments are known compounds. However, determining the effective doses and the population for which such administration is therapeutically effective may involve experimental developments, as well as considerable economic efforts. In this context, it is of interest to know whether this “personalized medical use” resulting from research can be protected by a patent.

In other words, is it possible to claim a compound X for the treatment of disease Y administered to patients that share feature Z or, alternatively, a treatment for disease Y comprising administering a compound X to patients that share feature Z?

Under the European patent system, the possibility of second medical uses claims is provided by Art 54(5) EPC. A medical use of a known compound X may confer novelty to a claim directed to compound X for the treatment of disease Y, as long as said treatment does not form part of the state of the art. If a related technical effect is demonstrated, the therapeutic indication may be considered as a functional feature of the claim, conferring novelty to the claim in accordance with decision G 2/88 of the Enlarged Board of Appeal.

Later on, in decision G 2/08 of 2010, the Enlarged Board stated that a new mode of administration or dosage regime of compound X, or even the treatment of the same disease Y in a new group of patients, could contribute to the novelty of a medical use even if the general use of compound X for the treatment of disease Y were already known. This decision also set forth the prohibition of “Swiss type” claims for second medical uses under the European system.

In 2019, decision T 694/16 of a Technical Board of Appeal reaffirmed these principles and extended them specifically to personalized medicine. The case at issue was related to a known compound for the treatment of dementia, where the use of such compound in patients presenting a specific biological marker detectable in cerebrospinal fluid was claimed. According to patent EP2170104, this marker allows to distinguish between patients in prodromal phase, who will develop dementia, and patients presenting cognitive symptoms but who will not necessarily develop dementia. For the Board of Appeal, the selection of a subgroup of patients based on a feature Z (the common biological marker) may contribute to the novelty of a personalized medicine claim: the functional relationship between markers that characterize patients and the therapeutic effect which is sought is an essential technical feature of the claim. Moreover, prior art describing the use of compound X for the treatment of a disease Y in a group of patients including the subgroup having feature Z does not inherently or inevitably disclose this functional relationship and does not affect novelty of the claim.

With this decision, the European Patent Office confirms that it is possible to obtain European patents related to personalized medicine, even if the general use of an active principle in a determined treatment is known in the state of the art. To obtain a valid patent, the personalized treatment must also meet the inventive step requirement, meaning that it must not be obviously derivable from the prior art.

In Argentina, according to a Joint Ministry Resolution issued by the Patent Office and the Ministry of Health in 2012, second medical uses are not deemed patentable: nowadays, personalized medicine may hardly be the object of a patent of invention, regardless of whether novelty and inventive step criteria are met. Other Latin American countries accept second medical uses, as long as they are claimed according to local practice and all other patentability requirements are met.

In general, claims directed to uses are not accepted in the United States, although therapeutic methods for treatment are permitted. Nonetheless, the doctrine of inherency and anticipation practice under the US patent system may make it difficult to protect personalized medicine as compared to the European system.

Share

Emilio Berkenwald

Emilio is a patent engineer specialized in the fields of chemistry, industrial chemistry and materials engineering. He is involved in patent drafting, translation, filing and prosecution of patent application of domestic and foreign clients in Argentina and Latin America.
Leaders League 2020 RankingPrev
WIPO PROOF: new “digital fingerprint”Next

Latest Posts

by Ernesto Machicote

Pat-INFORMED by WIPO

Pat-INFORMED, A PATENT INFORMATION TOOL FOR PHARMACEUTICALS “Pat-INFORMED” (Patent Information Initiative for Medicines) by WIPO is a database containing...

Pat-INFORMED by WIPO

IP NewsDecember 4, 2020
Share
by BERKEN IP

IAM Global Leaders 2021

Our Managing Partner Alicia Alvarez Berkenwald has been recognized by IAM as a Global Leader in Patents in the just released 2021 IAM Global...

IAM Global Leaders 2021

International PublicationsNovember 25, 2020
Share

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent posts

  • Pat-INFORMED by WIPO
  • IAM Global Leaders 2021
  • 2020 INTA Annual Meeting
  • Webinar on Argentine IP Law at CEIPI
  • 2020 Women in IP Virtual Global Networking Event

Archive

  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • February 2019

Categories

  • BERKEN IP News
  • Biotechnology
  • General interest
  • International Publications
  • IP Associations
  • IP News
  • IP Training
  • Regulatory Affairs

Tags

AIPLA aippi Argentine Ceipi CEIPIDroitComparé chambersandpartners chamberslatinamerica confinement2 covid-19 germany grur IAM IAMGlobalLeaders IAMPatent1000 inpi INTA INTAconnect IP patent Patents Strasbourg trademarks Unista USPTO WIPNE wipo WomeninIP
logo

BERKEN IP is an Intellectual Property Law Firm focused on Patents, Technology & Business, located in Buenos Aires, Argentina.

Quick menu

  • About the Firm
  • Team
  • Services

Services

  • Intellectual Property Prosecution
  • Legal Affairs
  • Patent Intelligence

Technology Areas

  • – Biotechnology, Chemical & Pharmaceutical
  • – Electronics and Information Technology
  • – Industrial Chemistry and Mechanics

Contact us

  • Email
  • Map
  • Twitter
  • LinkedIn

© 2020 BERKEN IP. All rights reserved | Legal Notice | Personal Data Policy

We use cookies to customize and enhance your experience on our website and optimize the information we offer you. By clicking “accept” you agree to the use we make of cookies.AcceptCookies policy